Solvay SA (SOL.F)
| Previous Close | 30.11 |
| Open | 29.92 |
| Bid | 29.70 x 16000 |
| Ask | 31.18 x 16000 |
| Day's Range | 29.92 - 30.01 |
| 52 Week Range | 18.50 - 31.49 |
| Volume | |
| Avg. Volume | 263 |
| Market Cap | 3.194B |
| Beta (5Y Monthly) | 1.00 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | 1.62 (5.40%) |
| Ex-Dividend Date | Jun 03, 2024 |
| 1y Target Est | N/A |
- GlobeNewswire
Solvay first quarter 2024 results
Strong FCF supported by resilient EBITDA and discipline on costs and capex Brussels, May 7, 2024 – 7:00 am CEST - regulated information Highlights Net sales for Q1 2024 at €1,201 million were down -11.9% organically versus Q1 2023, with positive volume impact, for the first time in seven quarters, in both Basic and Performance Chemicals segments. Prices decreased, mostly reflecting the lower energy and raw material costs.Underlying EBITDA of €265 million for the first quarter was -13.6% lower or
- GlobeNewswire
Participation notification by UBS Group AG
Brussels, April 29, 2024, 08:30 CEST - Regulated information In line with Belgian transparency legislation (Law of May 2, 2007), UBS Group AG recently sent to Solvay the following transparency notification indicating that they crossed the threshold of 5%. The notification, dated April 23, 2024, contains the following information: Reason for the notification: acquisition or disposal of financial instruments that are treated as voting securities. Notified by: A parent undertaking or a controlling
- GlobeNewswire
Solvay publishes notice of 2024 Annual General Meeting
Brussels, April 26, 2024, 8:00am CEST - regulated information Solvay today published materials for its next Ordinary General Shareholders’ Meeting, which will be held on Tuesday May 28, 2024 at the Event Lounge Conference Center, Boulevard Général Wahis 16/F, 1030 Brussels, at 10.30 am CEST. All documents relating to this meeting are now available on www.solvay.com. Shareholders will be asked to vote on a number of resolutions, among others: the approval of the financial statements for the finan
